-
Triple-Targeted Drug Combination Shows Promise Against Pancreatic Cancer
January 30, 2026Pancreatic cancer is one of the most aggressive and lethal malignancies, with survival rates that have...
-
CORONA Remedies Limited Secures EAEU–GMP Certification, Strengthening Global Presence
January 22, 2026Ahmedabad-based CORONA Remedies Limited has achieved a major milestone in its international growth journey with the...
-
Zydus Receives USFDA Orphan Drug Designation for Desidustat in Beta-Thalassemia Treatment
November 6, 2025In a significant step toward advancing treatments for rare blood disorders, Zydus Lifesciences Limited has announced...
-
Russian mRNA Cancer Vaccine Enteromix Sparks Hope — But Experts Urge Caution
September 9, 2025Enteromix represents hope tempered with caution. The vaccine is a reminder that while science continues to...
-
Serena Williams’ GLP-1 Weight Loss Drug Deal Sparks Debate on Body Image and Celebrity Influence
August 27, 2025To see Serena Williams promoting injections for weight loss, critics argue, marks a turning point where...
-
Ozempic Faces $2 Billion in Lawsuits as Patients Report Stomach Paralysis and Vision Loss
August 26, 2025Ozempic, along with sister drugs Wegovy and Rybelsus, belongs to the GLP-1 receptor agonist class of...
-
Johnson & Johnson Launches The 3rd Opinion to Empower Lung Cancer Patients Across Asia Pacific
August 1, 2025Marking World Lung Cancer Day, Johnson & Johnson has unveiled The 3rd Opinion, a groundbreaking initiative...
